Received Nov 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z009077 | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
No additional AE reported.; Office Manager who is also a Medical Assistant reported PROQUAD was administered to one patient on 11/13/2025 during a temperature excursion.; This spontaneous report was received from an office manager who was also a medical assistant (physician assistant) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, previous drugs reactions and allergies were not reported. On 13-Nov-2025, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA [recombinant Human albumin]) (PROQUAD) injection (Lot No. Z009077 has been verified to be a valid lot number for [measles, mumps, rubella and varicella (oka-merck) virus vaccine live], expiration date not reported, but upon internal validation established as 15-Nov-2026) (strength, dose number, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided); that was reconstituted with sterile diluent, injection (Lot No., expiration date, route and indication were not provided) (product storage error), after a temperature excursion of 6.8 degree Fahrenheit (F) during a time frame of 1 hour and 20 minutes. No previous temperature excursion was reported. No additional adverse events were reported (no adverse event).